Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma. (Q43829586)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Predictive and prognostic roles of ribonucleotide reductase M1 in resectable pancreatic adenocarcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Wei Jiang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

John Jiang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Yixin Wang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Richard Kim

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Xiaobo Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Xiuli Liu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

26 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

173-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22736490%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Gene expression levels as predictive markers of outcome in pancreatic cancer after gemcitabine-based adjuvant chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

RRM1-induced metastasis suppression through PTEN-regulated pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Gemcitabine metabolic and transporter gene polymorphisms are associated with drug toxicity and efficacy in patients with locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Unbiased Recursive Partitioning: A Conditional Inference Framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Empiric comparison of multivariate analytic techniques: advantages and disadvantages of recursive partitioning analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Experiments to determine whether recursive partitioning (CART) or an artificial neural network overcomes theoretical limitations of Cox proportional hazards regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715

A comment on the utility of recursive partitioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27715